Form 4 for TECH Bio-Techne
Accepted 2026-07-30 16:11:16 ET · period of report 2026-07-28 · accession 0000914190-26-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-30 16:11 | 2026-07-28 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $47.60 | +35.0K | 100.8K | +53% | +$1.67M |
| D | 2026-07-30 16:11 | 2026-07-28 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $72.07 | -28.7K | 72.1K | -28% | -$2.07M |
| D | 2026-07-30 16:11 | 2026-07-28 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -35.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | M | A | 35,000 | $47.60 | 100,799 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-28 | F | D | 28,686 | $72.07 | 72,113 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-07-28 | M | D | 35,000 | $0.00 | 0 | D | $47.60 · — to 2026-08-07 | 35,000 Common Stock | (F1) Fully exercisable. |